NIH – MPP, COVID-19 Patent and Biological Material License Agreement Post author:GHIAA Admin Post published:June 29, 2022 Post category: Continue ReadingNIH – MPP, COVID-19 Patent and Biological Material License Agreement
Elkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement Post author:GHIAA Admin Post published:May 27, 2022 Post category: Continue ReadingElkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement
CSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement Post author:GHIAA Admin Post published:May 23, 2022 Post category: Continue ReadingCSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement
Cellscript – BioNTech mRNA Technology Patent Sublicense Post author:GHIAA Admin Post published:March 17, 2022 Post category: Continue ReadingCellscript – BioNTech mRNA Technology Patent Sublicense
University of Washington – Medicines Patent Pool, Long-acting Injectable HIV Treatment License Agreement Post author:GHIAA Admin Post published:January 8, 2022 Post category: Continue ReadingUniversity of Washington – Medicines Patent Pool, Long-acting Injectable HIV Treatment License Agreement
Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement Post author:GHIAA Admin Post published:December 21, 2021 Post category: Continue ReadingOcugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement
MSD – MPP, Molnupiravir License Agreement Post author:GHIAA Admin Post published:November 19, 2021 Post category: Continue ReadingMSD – MPP, Molnupiravir License Agreement
CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement Post author:GHIAA Editor Post published:September 15, 2021 Post category: Continue ReadingCureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
Novavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement Post author:GHIAA Admin Post published:September 10, 2021 Post category: Continue ReadingNovavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement